cdp biotech biz 1.jpg
John L. Gainer, chief scientific consultant, and David G. Kalergis, CEO of Diffusion Pharmaceuticals, stand with a map that points to the locations with enrolled patients for the study of their product.
cdp biotech biz 2.jpg
John L. Gainer, chief scientific consultant, in the lab at Diffusion Pharmaceuticals Monday, March 18, 2013.
Posted: Sunday, March 24, 2013 7:00 pm
Updated: 7:40 pm, Sun Mar 24, 2013.
Posted on Mar 24, 2013
In an industry dominated by giants, the leaders of several small, local biotech companies see a new day rising where the world will reap the rewards from breakthroughs sown by the little guys.
One of the local companies, Albemarle County-based Diffusion Pharmaceuticals, recently completed enrollment of 56 patients around the country in a phase two clinical trial of trans sodium crocetinate, a brain cancer treatment compound. Five patients in the study are undergoing treatment at the University of Virginia Medical Center.
Sunday, March 24, 2013 7:00 pm.
Updated: 7:40 pm.